Replies to post #3622 on Galectin Therapeutics Inc. (GALT)

[jimmy667]

It looks like some are buying the rumour of something. FDA acceptance of Phase 3 protocol maybe.
where do you get $44 million on hand? The June 30 Q10 stated $52 million. Did you reduce that figure by the burn rate? Also they have only S3 registered 1.7 million shares at maximum price of $3.51 for additional $6 million. Seems like very mild dilution for a company with 56.6 million shares outstanding. If your figures are correct of $44 million that would put cash back to $50 million.